iifl-logo-icon 1

Brooks Laboratories Ltd Board Meeting

144.01
(-2.00%)
Oct 11, 2024|12:00:00 AM

Brooks Lab. CORPORATE ACTIONS

16/10/2023calendar-icon
15/10/2024calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting14 Aug 20246 Aug 2024
BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve the Unaudited Standalone & Consolidated Financial Results of the Company for the quarter ended on June 30 2024
Board Meeting7 Aug 20247 Aug 2024
Appointment of Additional Independent Director(s).
Board Meeting18 May 202412 May 2024
BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2024 inter alia to consider and approve Audited Standalone and Consolidated Financial Results of the company for the quarter and year ended 31st March 2024. Board Meeting Outcome For Submission of Audited Standalone And Consolidated Financial Results For Quarter And Financial Year Ended March 31, 2024. Financial Results for Quarter and Financial Year ended March 31,2024 (As Per BSE Announcement Dated on 18.05.2024)
Board Meeting31 Jan 202424 Jan 2024
BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve the unaudited standalone and consolidated financial results. Approval of Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2023. (As per BSE Announcement Dated on 31/01/2024)
Board Meeting24 Jan 202416 Jan 2024
BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2024 inter alia to consider and approve fund raising through Rights issue. The Board Meeting to be held on 24/01/2024 Stands Cancelled. Further to our letter dated January 16, 2024, intimating the exchange about the Board Meeting to be held on January 24, 2024, we further wish to inform that the agenda items are amended as below: (As per BSE Announcement Dated on 17/01/2024) Issue Of Warrants & Preferential Issue of shares & Rights Issue (As per BSE Bulletin dated on 17/01/2024) Outcome of Board Meeting (As Per BSE Announcement dated on 24.01.2024)
Board Meeting9 Nov 202331 Oct 2023
BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the Half year and quarter ended September 30 2023. Outcome of Board Meeting Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th September,2023 along with Review Report issued by M/s J C Ranpura & Co. Chartered Accountant for the quarter /half year ended 30th September,2023 Financial Results for September 30, 2023 (As Per BSE Announcement Dated on 09/11/2023)

Brooks Lab.: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS

  • Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020
  • Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
  • Pay 20% upfront margin of the transaction value to trade in cash market segment.
  • Investors may please refer to the Exchange’s Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.
  • Check your Securities / MF / Bonds in the consolidated account statement issued by NSDL/CDSL every month.
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day.” – Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp